Mass Torts: State of the Art

TIDE Trial on Hold; Likely Never to be Completed

That's it for Avandia. The FDA has put the TIDE trial "on full clinical hold and the regulatory deadlines for its conduct are rescinded." The plan is to reassess the data from the RECORD trial to see if reliable "ischemic risk can be obtained from [] re-adjudication..." In Europe physicians have been directed to stop prescribing the drug. Meanwhile, in the U.S., patients will still be able to get the drug if they are already on it or have tried other drugs like pioglitazone without success.

Trackbacks (0) Links to blogs that reference this article Trackback URL
Comments (0) Read through and enter the discussion with the form at the end
Vorys, Sater, Seymour and Pease LLP
Columbus, Ohio
52 East Gay Street
PO Box 1008
Columbus, Ohio 43216-1008
Phone:
614.464.6400
Washington, D.C.
1909 K Street NW
Suite 900
Washington, D.C. 20006-1152
Phone:
202.467.8800
Cleveland, Ohio
200 Public Square
Suite 1400
Cleveland, Ohio 44114-2327
Phone:
216.479.6100
Cincinnati, Ohio
301 East Fourth Street
Suite 3500, Great American Tower
PO Box 0236
Cincinnati, Ohio 45202
Phone:
513.723.4000
Akron, Ohio
106 South Main Street
Suite 1100
Akron, Ohio 44308
Phone:
330.208.1000
Houston, Texas
700 Louisiana Street
Suite 4100
Houston, Texas 77002
Phone:
713.588.7000
Pittsburgh, Pennsylvania
500 Grant Street
Suite 4900
Pittsburgh, Pennsylvania 15219
Phone:
412.904.7700